More articles from Letters to the Editor

You have access
FDA Reconsiders Rules Around Radiation Dosimetry for First-in-Human Studies of Investigational PET Radiopharmaceuticals
Marianna Dakanali, Steven S. Zigler, Sally W. Schwarz, Michael L. Nickels, Reiko Oyama, Henry F. VanBrocklin and Peter J. H. Scott

Journal of Nuclear Medicine April 17, 2025, jnumed.125.269885; DOI: https://doi.org/10.2967/jnumed.125.269885
You have access
Patient-Specific Dosimetry-Driven PRRT: Time to Move Forward!
Emmanuel Deshayes, Ioannis Karfis, Lore Santoro, Magdalena Mileva, Rachele Danieli, Kévin Hebert, Marco Maccauro, Carlo Chiesa and Manuel Bardiès

Journal of Nuclear Medicine April 10, 2025, jnumed.124.268880; DOI: https://doi.org/10.2967/jnumed.124.268880
You have access
[⁶⁸Ga]Ga-RAYZ-8009: A Peptide PET Tracer for Targeting HCC in Humans
Yue Zhang, Jiangtao Yue, Xuhong Yang, Guanghai Fei, Yicheng Ni and Yue Li

Journal of Nuclear Medicine April 10, 2025, jnumed.124.269294; DOI: https://doi.org/10.2967/jnumed.124.269294
You have access
¹⁷⁶Lu Radiation Dose of Long–Axial Field of View PET Scanners
Samaneh Mostafapour, Joyce van Sluis, Adriaan A. Lammertsma and Charalampos Tsoumpas

Journal of Nuclear Medicine April 1, 2025, 66 (4) 663; DOI: https://doi.org/10.2967/jnumed.124.269187
You have access
The PRIMARY Score: Present and Future
Linlin Guo and Guohua Shen

Journal of Nuclear Medicine April 1, 2025, 66 (4) 663-664; DOI: https://doi.org/10.2967/jnumed.124.267898
You have access
The Value of Functional PET in Quantifying Neurotransmitter Dynamics
Murray B. Reed, Matej Murgaš, Rupert Lanzenberger and Andreas Hahn

Journal of Nuclear Medicine March 13, 2025, jnumed.124.269238; DOI: https://doi.org/10.2967/jnumed.124.269238
Open Access
Determining PSMA-617 Mass and Molar Activity in Pluvicto Doses
Ivan E. Wang, Allen F. Brooks, Peter J. Scott and Benjamin L. Viglianti

Journal of Nuclear Medicine March 13, 2025, jnumed.124.269111; DOI: https://doi.org/10.2967/jnumed.124.269111
You have access
Reply: On Facilitating the End of the Linear No-Threshold Era
Mohan Doss

Journal of Nuclear Medicine March 1, 2025, 66 (3) 483-484; DOI: https://doi.org/10.2967/jnumed.124.269292
You have access
On Facilitating the End of the Linear No-Threshold Era
Eduardo Galiano

Journal of Nuclear Medicine March 1, 2025, 66 (3) 483; DOI: https://doi.org/10.2967/jnumed.124.269042
You have access
Reply: A Comment on “Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy for Nonmelanoma Skin Cancer: Interim Results from the EPIC-Skin Study”
Gerhard Dahlhoff

Journal of Nuclear Medicine March 1, 2025, 66 (3) 485; DOI: https://doi.org/10.2967/jnumed.124.269115

Main menu

User menu

Search

More articles from Letters to the Editor

Pages